Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Investing

5 Biggest Biotechnology ETFs in 2024

by March 8, 2024
March 8, 2024
5 Biggest Biotechnology ETFs in 2024

Investing in the biotech industry can be a long road to gains given the sector’s volatility.

Even with a good understanding of the system, no one can predict which treatment, device or therapy will give the biggest return, making biotech exchange-traded funds (ETFs) a more secure option than individual biotech stocks.

An ETF is a relatively safe investment route that can minimize losses while offering exposure to multiple companies instead of focusing on the gains and losses of a single biotech stock. With that in mind, here’s a brief look at the five top biotechnology ETFs by total assets. Data was sourced from ETFdb.com on March 1, 2024, and all data was current as of that time.

1. SPDR S&P Biotech ETF (ARCA:XBI)

Company Profile

Total assets: US$8.153 billion

Established on February 6, 2006, the SPDR S&P Biotech ETF is a largely balanced fund in terms of weight that focuses mostly on biotech companies with some pharmaceutical companies. As noted by ETF.com, it focuses on small- and micro-cap companies, which makes the weight of each holding smaller than the holdings of other ETFs in this sector.

The SPDR S&P Biotech ETF has 122 companies in its portfolio, with the top three being: Viking Therapeutics (NASDAQ:VKTX) which has a 4.5 percent weighting; Iovance Biotherapeutics (NASDAQ:IOVA) weighted at 2.5 percent; and Cytokinetics (NASDAQ:CYTK) with a 2.22 percent weight.

2. iShares NASDAQ Biotechnology ETF (NASDAQ:IBB)

Company Profile

Total assets: US$7.78 billion

The iShares NASDAQ Biotechnology ETF was launched on February 5, 2001, and tracks 220 holdings. This iShares ETF is a diversified fund in that it provides exposure to biotechnology, pharmaceutical and life science tools and services. Its overarching investment goal is to track NASDAQ-listed companies focused on these areas.

Its top three holdings are: Vertex Pharmaceuticals (NASDAQ:VRTX), weighted at 8.82 percent; Regeneron Pharmaceuticals (NASDAQ:REGN) with a 8.72 percent weight; and Amgen (NASDAQ:AMGN) at a weight of 7.55 percent.

3. ARK Genomic Revolution Multi-Sector ETF (ARCA:ARKG)

Company Profile

Total assets: US$1.915 billion

The ARK Genomic Revolution Multi-Sector ETF came into existence on October 31, 2014, and tracks 43 holdings. This ETF follows companies that develop products such as CRISPR technology, bioinformatics, molecular diagnostics and stem cells.

This top biotechnology ETF’s three most significant company holdings are: CRISPR Therapeutics (NASDAQ:CRSP), weighted at 8.21 percent; Recursion Pharmaceuticals (NASDAQ:RXRX) at a weight of 6.45 percent; and Twist Bioscience (NASDAQ:TWST) at 5.97 percent.

4. Direxion Daily S&P Biotech Bull 3x Shares ETF (ARCA:LABU)

Company Profile

Total assets: US$1.36 billion

Founded on May 28, 2015, the Direxion Daily S&P Biotech Bull 3x Shares ETF does not mirror an index. Instead, its goal is to obtain daily investment results of at least 300 percent of the S&P Biotechnology Select Industry Index.

Like some of the other ETFs on this list, companies in the Direxion Daily S&P Biotech Bull 3x Shares ETF have an equally weighted average. Its top holdings include: Viking Therapeutics (NASDAQ:VKTX), which has a 3.13 percent weight; Iovance Biotherapeutics with a weight of 1.95 percent; and Cytokinetics at a weight of 1.87 percent.

5. First Trust NYSE Arca Biotechnology Index (ARCA:FBT)

Company Profile

Total assets: US$1.189 billion

The First Trust NYSE Arca Biotechnology ETF entered the market on June 23, 2006, and aims to track the NYSE Arca Biotechnology Index as closely as it can. Companies in this fund are generally involved in areas such as recombinant DNA technology, molecular biology, genetic engineering and genomics.

The fund has only 31 holdings; this means they are largely equally weighted. The top three holdings of the fund are the following large-cap companies: Natera (NASDAQ:NTRA) at a 4.78 percent weighting; Bruker Corporation (NASDAQ:BRKR) representing a 4.09 percent weight, and Halozyme Therapeutics (NASDAQ:HALO), coming in at a 3.89 percent weight.

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
David Erfle: Gold Stock Mean Reversion About to Happen, Watch Silver Too
next post
Hamas terror attack exposes Al Jazeera for what it really is

Related Posts

Quebec’s Potential as Key Player in North American...

August 24, 2023

Crypto Market Recap: WLFI Unveils Strategic Token Reserve

February 15, 2025

Rio Silver Announces Grant of Stock Options

May 8, 2024

Ramp Metals Announces Receipt of Exploration Drill Permits

March 10, 2025

Drilling Underway at Trafalgar High-Grade Gold Prospect

April 18, 2024

FireFly Metals to Add AU$95 Million to Coffers...

June 12, 2025

Up to 67g/t Au Intersected in Drilling at...

May 29, 2024

Cyclopharm Signs US Agreement with HCA Healthcare for...

January 23, 2025

RecycLiCo Battery Materials and Zenith Chemical Announce a...

June 13, 2023

5 Top Weekly TSXV Stocks: Arianne Phosphate Grows...

January 29, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Joe Rabil’s Undercut & Rally Pattern: From DROP to POP

    • RRG Alert Tech Vaults to ‘Leading’—Is XLK Signaling a New Rally?

    • Coelacanth Energy

    • Jeffrey Christian: Gold, Silver, PGMs — Short-term Prices and Key Drivers

    • Ericsson, Rogers Launch Canada’s First Underground 5G Network for Smart Mining

    • Crypto Market Recap: Bitcoin Price Stalls as Fed Holds Rates Steady, Circle Shares Jump

    Categories

    • Business (1,259)
    • Investing (2,583)
    • Politics (3,699)
    • Stocks (1,669)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved